Lateral Flow Assays Market is poised to value over USD 12.5 billion during the forecast period 2022 to 2028. Lateral flow assays are immunochromatographic procedures that can detect the presence or absence of target analytes in humans or animals, such as infections or biomarkers. Lateral flow assays are cellulose-based devices that detect the presence of a target component in a liquid sample without the use of costly or specialised equipment.